---

Market Overview

---

The Laboratory Filtration Market is projected to witness substantial growth, with its size expected to increase from USD 3,516.4 million in 2023 to USD 4,959.7 million by 2028, at a Compound Annual Growth Rate (CAGR) of 7.12% during the forecast period (2023-2028).

The outbreak of the COVID-19 pandemic has had a significant impact on the laboratory filtration market. The heightened demand for vaccine development and manufacturing during the pandemic has led to an increased adoption of laboratory filtration techniques. Various filtration methods have been employed in vaccine manufacturing processes. For instance, a research study published by the NCBI in April 2021 highlighted the streamlining of new purification and filtration methods to scale up vaccine production during the pandemic. The study also noted that researchers at Michigan Technological University devised novel processes to enhance the purification and filtration steps, which constitute a substantial portion (50.0% to 70.0%) of vaccine manufacturing costs. The use of laboratory filtration equipment is integral to vaccine filtration procedures. Consequently, the surge in vaccination initiatives has positively impacted the laboratory filtration market and is expected to sustain the upward trend throughout the forecast period.

Several factors drive the market growth, including the launch of new and transformative technologies in lab filtration, increasing vaccination initiatives, favorable patient demographics, and the growing vaccination rates among newborns and children. For instance, the ‘Tika Express’ program launched in October 2021 aimed to expedite vaccination in Visakha Agency. Mobile vans carrying healthcare staff administered vaccines to people on-site through organized camps in remote areas. Additionally, the National Immunization Awareness Month conducted in August 2022 aimed to raise awareness about the importance of vaccination in preventing chronic and fatal diseases. Moreover, Touchlight’s pre-clinical development of its proprietary doggybone DNA vaccine platform received significant financial support from the Bill & Melinda Gates Foundation through a grant of USD 2.4 million. The initiatives supporting vaccinations are expected to bolster vaccine production, thereby driving the demand for laboratory filtration equipment. Consequently, substantial market growth is anticipated during the forecast period.

Furthermore, favorable patient demographics and an increasing trend of vaccinations among newborns and children contribute to the market’s expansion. For instance, data published by the American Academy of Pediatrics in March 2022 revealed that over 1 million people in the United States have long-term hepatitis B infections, with those infected as babies having a 90% chance of developing serious, chronic conditions like liver cancer during their lifetime. Additionally, chickenpox infects around 4 million people in the United States annually, resulting in hospitalizations and fatalities. The prevalence of these diseases drives the need for vaccinations to reduce morbidity, mortality, and economic burden. Consequently, there is a growing emphasis on vaccinating newborns and children, leading to an accelerated rate of vaccine manufacturing. As laboratory filtration plays a crucial role in vaccine production, the increased rate of manufacturing is expected to drive the demand for laboratory filtration equipment, further boosting market growth.

However, there are certain factors that may impede the market’s growth during the forecast period, such as the reuse of sterilizing-grade filters and the high cost of specialized filters. These challenges may pose obstacles to the widespread adoption of laboratory filtration techniques in certain applications.

---

Market Segmentation

---

The market is segmented based on various factors, including Technology, Product, and Geography.

Segmentation by Technology
Microfiltration
Ultrafiltration
Reverse Osmosis
Vacuum Filtration
Nanofiltration

Segmentation by Product
Filtration Media – Membrane Filters, Filter Papers, Filtration Microplates, Syringeless Filters, Syringe Filters, Capsule Filters
Filtration Assemblies – Microfiltration Assemblies, Ultrafiltration Assemblies, Vacuum Filtration Assemblies, Reverse Osmosis Assemblies, Nanofiltration Assemblies
Filtration Accessories

Segmentation by Geography
North America – United States, Canada, and Mexico
Europe – United Kingdom, Germany, France, Italy, Spain, and Rest of Europe
Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific
Latin America – Brazil, Argentina, and Rest of Latin America
Middle East and Africa – GCC, South Africa, and Rest of Middle East and Africa

Ultrafiltration is a process used to separate extremely small particles and dissolved molecules from liquids. The primary criterion for separation is the size of the molecules, although the filter’s permeability can also be influenced by the sample’s chemical, molecular, or electrostatic properties. To undergo ultrafiltration, molecules must differ in size by at least an order of magnitude and have a molecular weight ranging from 1 kDa to 1000 kDa. Ultrafiltration membranes serve various purposes, such as cleaning the filtrate or collecting the retentate. This technique finds common use in separating proteins from buffer components for buffer exchange, concentration, or desalting.

The significant drivers for the growth of this segment are the advantages and wide applicability of ultrafiltration, including its use in protein purification and isolation, vaccine manufacturing, and increased investments in research and development. Studies, such as one published by the NCBI in January 2021, highlight the beneficial application of membrane filtration methods like ultrafiltration in concentrating products or isolates from various protein sources. Additionally, the advantages of ultrafiltration technology, such as high product throughput and rapid results generation, contribute to its extensive adoption. Furthermore, traditional techniques like chromatography often require complex instrumentation and result in low product throughput at a considerable cost, making ultrafiltration a more appealing alternative due to its ability to overcome these disadvantages.

Moreover, the rising demand for vaccines is expected to boost the growth of the ultrafiltration segment. For example, in February 2022, India’s Union Minister for Health and Family Welfare Dr. Mansukh Mandavia launched the National Polio Immunization Drive, highlighting the importance of vaccine production. Thus, the increasing demand for vaccines is likely to propel segment growth as vaccine ultrafiltration is a crucial step in the vaccine production and manufacturing process. Consequently, the advantages of ultrafiltration, its broad applicability, and increased vaccine production are expected to drive the segment’s growth in the foreseeable future.

North America is anticipated to experience substantial growth during the forecast period. This growth is attributed to increasing research efforts and rising investments in research and development by both the public and private sectors. Reports indicate that the estimated Medical and Health R&D Investment in the United States exceeded USD 245,127 million in 2021, showing an increase from around USD 221,438 million in 2020. Additionally, the investment in R&D by industrial players also rose, surpassing USD 161,766 million in 2021 compared to approximately USD 148,205 million in 2020. These increased investments indicate a focus on developing new and advanced products, creating new opportunities for the laboratory filtration market. As a result, these factors are expected to foster market growth in North America.

The key drivers for the market’s growth in the region include key product launches, a high concentration of market players or manufacturers’ presence, and various acquisitions and partnerships among major players. Moreover, the increased R&D investments by biopharmaceutical companies in the United States contribute to the expansion of the laboratory filtration market. For instance, in October 2021, the United States National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) approved a USD 3.0 million grant for six new biopharmaceutical manufacturing devices. Several institutions, including North Carolina State University, the University of Massachusetts, the University of Georgia, the University of Michigan, the University of Delaware, and Carnegie Mellon University, will benefit from this funding. Such regional R&D investments are expected to drive market growth. Furthermore, the introduction of new membrane filters and related filtering systems through product launches is likely to fuel market expansion in the region. For instance, in November 2021, DuPont Water Solutions (DWS) launched the TapTec LC HF-4040 reverse osmosis membrane filter, which combines high flow rates with reliability. Therefore, due to increased investments in research and development and product launches in the United States, significant market growth is expected in this country during the forecast period.

---

Competitive Landscape

---

The Laboratory Filtration Market is poised to witness intensified competition as numerous key players prioritize the expansion of their laboratory filtration portfolio through acquisitions and collaborations with other companies. This development is expected to create various opportunities for both new entrants and established market leaders. The competitive landscape comprises an analysis of several international and local companies, including well-known entities such as 3M Company, Merck KGaA, Danaher Corporation (Pall Corporation), Sartorius Group, and GVS S.p.A, among others, who hold significant market shares.

Key companies profiled in this report include 3M Company, Merck KGaA, Danaher Corporation, Sartorius AG, GVS SpA, Antylia Scientific (Cole-Parmer Instrument Company LLC), Agilent TechnologiesInc, Ahlstrom-Munksjo, MACHEREY-NAGEL GmbH & Co. KG, Thermo Fisher Scientific Inc.

---

Recent Industry Developments

---

In September 2022, Pall Corporation introduced a trio of new Allegro Connect Systems. These innovative products encompass systems designed to support Depth Filtration, Virus Filtration, and Bulk Fill of drug substances, along with a Buffer Management System aimed at streamlining the creation of manufacturing workflows.

Furthermore, in April 2022, Eaton expanded its selection of filter media containing activated carbon. The enhanced BECO CARBON depth filter sheets possess remarkably high adsorption properties, making them well-suited for the rigorous filtration of liquids. These filters excel in decolourisation and effectively remove undesired by-products, while also correcting taste, odor, and color, making them particularly ideal for utilization in the pharmaceutical and biotechnology industries.

---

Key Questions Answered

---

What is the study period of the Laboratory Filtration Market?
The Laboratory Filtration Market has been studied from 2018 to 2028.

What is the growth rate of the Laboratory Filtration Market?
The Laboratory Filtration Market is experiencing a growth rate of 7.12% over the next 5 years.

What is the size of the Laboratory Filtration Market?
The Laboratory Filtration Market is expected to reach USD 3,516.4 million in 2023 and is projected to grow at a CAGR of 7.12% to reach USD 4,959.7 million by 2028.

Which region has the highest growth rate in the Laboratory Filtration Market?
The Asia-Pacific region is witnessing the highest CAGR growth over the period 2018-2028.

Which region has the largest share in the Laboratory Filtration Market?
North America holds the highest market share in 2022.

Who are the key players in the Laboratory Filtration Market?
The major companies operating in the Laboratory Filtration Market include Merck KgaA, Danaher Corporation, 3M Company, Sartorius AG, and GVS S.p.A.